Alcohol abuse can result in health problems including memory loss, poor decision making, fetal damage, liver diseases, hypertension and cardiovascular problems... but 'tis the season...
As Statista's Niall McCarthy notes, a recent report by the United Health Foundation found that 18.5 percent of U.S. adults engage in binge or chronic drinking.
You will find more statistics at Statista
The twin scourges of opioid addiction and worsening wealth inequality are literally draining the lifeblood from the American public. Case in point: The Centers for Disease Control confirmed earlier today that the average life expectancy at birth declined in 2016 for the second consecutive year - the first multiyear decline since 1963, when a flu epidemic led to a rash of deaths as hundreds of thousands of elderly Americans succumbed to the virus.
The increase has been fueled by a 21% rise in drug overdose deaths, according to the Washington Post.
The mystery whether John McCain will be present during next week's historic tax bill vote is over: according to CBS, the Arizona Senator will not be on hand for the final vote on the Republican tax bill, expected early this week, and instead is returning to Arizona after spending several days in a Maryland hospital recovering from side effects from chemotherapy treatment for brain cancer. As CBS furter notes, McCain left Washington Sunday and is heading back to his home state to spend the holidays with his family.
In recent months, it seems like there’s been nothing but bad news for Uber, like having its operating licence revoked in London (“not fit and proper”), concealing a massive cyber-attack, price gauging a passenger $14,000 for a 5-mile ride and reporting a quarterly loss of $1.5 billion. Indeed, the company is becoming almost synonymous with problems.
Avondale, a secretive Alabama-based drugmaker, has gained unwanted national attention after the company increased the price of a bottle of vitamins to almost $300 that can be bought on the internet for $5.
In the latest example of price-gouging in America’s lightly regulated pharmaceutical industry, records show Avondale inflated the price of Niacor, a prescription-only version of niacin, by “809 percent last month, taking a bottle of 100 tablets from $32.46 to $295”, according to the Financial Times.